# AbbVie Inc. (ABBV) — Q1-2025 Earnings Results

**Report date:** 2025-04-25 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q1-2025

## Post-Earnings Brief

### Headline

AbbVie Beats on EPS, Stock Up 3.15%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.46 | N/A | +2.93% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to shareholder value. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on delivering value to our shareholders.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

AbbVie's earnings report shows a positive surprise in EPS, which contributed to a 3.15% increase in stock price following the announcement. The lack of revenue data and guidance may leave some investors cautious, but the positive EPS performance indicates strong underlying business health. Overall, the market reacted favorably to the earnings beat.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q1-2025_